ophthalmologyadvisor1d
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
infectiousdiseaseadvisor.com3d
Risk for Venous Thromboembolism Is Reduced by COVID-19 Vaccination
The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.
News Medical3d
Practical tool helps predict epilepsy risk in venous stroke patients
A practical calculator that predicts the risk of epilepsy after venous stroke is presented in a study from the University of Gothenburg and others.